Showing results (51-60 of 279) with videos related to

Sort By:
Pageof 28
Blood Cancer Journal|December 20, 2023
Sociodemographic associations with uptake of novel therapies for acute myeloid leukemiaAndrew Hantel, Colin Cernik, Hajime Uno, et al.
The Oncologist|August 12, 2025
Barriers and Facilitators to Representative Acute Leukemia Trial Participation at National Cancer Institute-Designated Comprehensive Cancer CentersAndrew Hantel, Eric C Blackstone, Anna C Revette, et al.
Therapeutic Advances in Hematology|January 3, 2017
Exploratory study on the impact of switching to nilotinib in 18 patients with chronic myeloid leukemia in chronic phase with suboptimal response to imatinibSikander Ailawadhi, Luke P Akard, Carole B Miller, et al.
Seminars in Oncology|May 3, 2008
Optimizing outcomes for patients with advanced disease in chronic myelogenous leukemiaFrancis J Giles, Daniel J DeAngelo, Michele Baccarani, et al.
Plos One|October 7, 2014
A multicenter phase I/II study of obatoclax mesylate administered as a 3- or 24-hour infusion in older patients with previously untreated acute myeloid leukemiaAaron D Schimmer, Azra Raza, Thomas H Carter, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 28, 2006
Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndromeEdwin P Alyea, Haesook T Kim, Vincent Ho, et al.
British Journal of Haematology|March 9, 2017
Self-reported sleep disturbance and survival in myelodysplastic syndromesMarlise R Luskin, Angel M Cronin, Robert L Owens, et al.
Leukemia & Lymphoma|August 11, 2011
Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panelWendy Stock, Dan Douer, Daniel J DeAngelo, et al.
British Journal of Haematology|January 8, 2011
The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocolsRachael F Grace, Suzanne E Dahlberg, Donna Neuberg, et al.
Leukemia Research|May 7, 2013
Predictive factors for all-trans retinoic acid-related differentiation syndrome in patients with acute promyelocytic leukemiaHoury Leblebjian, Daniel J DeAngelo, J Andrew Skirvin, et al.
Pageof 28